Stockscreener 앱 받기
103.22
0.29%
0.30
시간 외 거래:
103.22
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
Is Mirum Pharmaceuticals on a Strong Path to Profitability? - Finviz
Is Mirum Pharmaceuticals on a Strong Path to Profitability? - The Motley Fool
EV Market: Is Mirum Pharmaceuticals Inc impacted by rising rates2025 Winners & Losers & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Aug PreEarnings: Is Tronox Holdings plc impacted by rising ratesIndex Update & Trade Opportunity Analysis - baoquankhu1.vn
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $123.00 at Morgan Stanley - MarketBeat
Chronic hepatitis D market set for steady growth as pipeline inches forward - The Pharma Letter
H.C. Wainwright Raises PT on Mirum Pharmaceuticals For the Second Time In a Span of Two Weeks, Here is Why? - Finviz
11 Best Stocks to Buy for Investment - Insider Monkey
Subdued Growth No Barrier To Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) With Shares Advancing 25% - simplywall.st
HC Wainwright Has Negative Outlook of MIRM FY2027 Earnings - MarketBeat
Mirum Director Sells $400K Amid 91% Stock Surge -- Here's What the Firm Expects for 2026 - AOL.com
Heron Patrick J buys Mirum Pharmaceuticals shares worth $8.99m By Investing.com - Investing.com UK
Heron Patrick J buys Mirum Pharmaceuticals shares worth $8.99m - Investing.com
Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Sells 1,053 Shares of Stock - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) COO Sells $302,325.17 in Stock - MarketBeat
Jolanda Howe Sells 842 Shares of Mirum Pharmaceuticals (NASDAQ:MIRM) Stock - MarketBeat
Christopher Peetz Sells 6,831 Shares of Mirum Pharmaceuticals (NASDAQ:MIRM) Stock - MarketBeat
3 Stocks That May Be Trading Below Estimated Value By Up To 48.2% - simplywall.st
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics - FinSMEs
Mirum acquires Bluejay Therapeutics to expand rare liver disease pipeline - Yahoo Finance
FY2030 Earnings Forecast for MIRM Issued By HC Wainwright - MarketBeat
Baird updates Mirum Pharmaceuticals (MIRM) valuation following beat-and-raise earnings results - MSN
Is Mirum Pharmaceuticals About to Soar in 2026? - Nasdaq
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 12-Month High After Analyst Upgrade - MarketBeat
Aug Swings: What is the earnings history of Mirum Pharmaceuticals IncTrade Volume Report & Daily Technical Forecast Reports - baoquankhu1.vn
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics; Closes Private Placements of $268.5 Million - marketscreener.com
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease - Investing News Network
H.C. Wainwright raises Mirum Pharmaceuticals stock price target on volixibat potential - Investing.com Canada
Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Expert Outlook: Mirum Pharmaceuticals Through The Eyes Of 11 Analysts - Benzinga
Moving Averages: Does Mirum Pharmaceuticals Inc meet Warren Buffetts criteriaJuly 2025 Recap & AI Driven Stock Price Forecasts - baoquankhu1.vn
Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Eric Bjerkholt Sells 1,421 Shares - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) SVP Sells $86,423.58 in Stock - MarketBeat
Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) COO Sells 2,382 Shares of Stock - MarketBeat
Christopher Peetz Sells 7,098 Shares of Mirum Pharmaceuticals (NASDAQ:MIRM) Stock - MarketBeat
Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Sells $170,047.26 in Stock - MarketBeat
Mirum Pharmaceuticals CEO Sells Shares - TradingView
Mirum Pharmaceuticals stock hits all-time high at 95.75 USD By Investing.com - Investing.com Australia
Baird Updates Mirum Pharmaceuticals (MIRM) Valuation Following Beat-and-Raise Earnings Results - Finviz
Mirum Pharmaceuticals stock hits all-time high at 95.75 USD - Investing.com
Mirum Pharmaceuticals, Inc. $MIRM Shares Acquired by Emerald Advisers LLC - MarketBeat
14 Best Mid-Cap Growth Stocks to Buy Right Now - Insider Monkey
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 52-Week HighHere's Why - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Joanne Quan Sells 6,911 Shares - MarketBeat
CorMedix vs. Mirum Pharma: Which Rare-Disease Stock is the Better Buy? - sharewise.com
Mirum stock rises 7% in a week: Here's what you should know - MSN
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Consensus Rating of "Buy" by Analysts - MarketBeat
23,566 Shares in Mirum Pharmaceuticals, Inc. $MIRM Bought by Campbell & CO Investment Adviser LLC - MarketBeat
1.27%
자본화:
|
볼륨(24시간):